Trevena, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
TRVN Over the counter 2836 www.trevena.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Trevena, Inc.

Trevena (TRVN) Could Find a Support Soon, Here's Why You Should Buy the Stock Now - Dec 10th, 2024 7:55 am
Trevena: Q3 Earnings Snapshot - Nov 7th, 2024 5:37 am
Trevena Reports Third Quarter 2024 Results and Provides Business Update - Nov 7th, 2024 5:01 am
Trevena Announces Receipt of Nasdaq Delisting Notification - Oct 4th, 2024 2:05 pm
Upcoming Stock Splits This Week (August 12 to August 16) – Stay Invested - Aug 12th, 2024 10:24 am
Trevena Announces Reverse Stock Split - Aug 8th, 2024 2:05 pm
Trevena: Q2 Earnings Snapshot - Aug 8th, 2024 5:21 am
Trevena Reports Second Quarter 2024 Results and Provides Business Update - Aug 8th, 2024 5:00 am
Sagimet Biosciences Announces Appointment of Anne Phillips and Jennifer Jarrett to its Board of Directors - Aug 1st, 2024 6:00 am
Trevena Announces $2M Non-Dilutive Financing Tranche and Reduction in Outstanding Liabilities in Connection with Existing ex-US Royalty Financing - Jul 8th, 2024 7:15 am